<DOC>
	<DOCNO>NCT00366379</DOCNO>
	<brief_summary>This study ass efficacy , safety tolerability increase dos GK Activator ( 2 ) patient type 2 diabetes whose condition optimally control one previous oral antihyperglycemic agent . After 2 week washout previous antidiabetic therapy , patient receive GK Activator ( 2 ) orally , twice day 12 week , increase dos 25mg bid 200mg bid ; dos titrate achieve target fast glucose level ( FPG ) &lt; 100mg/dL . The anticipated time study treatment &lt; 3 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Dose-Titration Study GK Activator ( 2 ) Patients With Type 2 Diabetes .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient , 1875 year age ; type 2 diabetes mellitus treat one oral antihyperglycemic agent &gt; =3 month prior screen . type 1 diabetes mellitus ; treatment insulin , PPAR agonists systemic corticosteroid 3 month prior screen ; woman pregnant , breastfeed use adequate contraceptive method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>